Novartis and existing investors GV, Kaiser Permanente Ventures and Roche Venture Fund helped the cancer test developer push its total funding past the $500m mark.

Mental health benefits provider Lyra Health once again secured funding from Providence Ventures, as part of a round that pushed its valuation to $1.1bn.

Corporate venturing units Slack Fund and Gradient Ventures contributed to a series B round that increased the online whiteboard developer's total funding to about $143m.

The database software provider advanced its valuation past the $1bn mark in a round featuring returning backer Dell Technologies Capital.

China's State Development and Investment Corporation has picked up an 18.6% stake in Sihuan Pharmaceutical’s drug development spinoff, Xuanzhu Biopharmaceutical.

Lilly Asia Ventures was among the new investors in a series C round for autoimmune and inflammatory disease drug developer Connect Biopharma.

CapitalG, which joined Dataiku’s shareholders through a secondary transaction last year, has now made its first primary investment in the data management software provider.

Medical care crowdfunding service Waterdrop has confirmed it raised $230m in its series D round, which was co-led by Swiss Re and Tencent.

Dizal, co-founded by AstraZeneca three years ago to develop therapies for a broad range of diseases, pulled in $100m through a round led by Lilly Asia Ventures.

The Alphabet and Roc Nation-backed share trading service boosted its valuation from $8.3bn to $11.2bn in the space of a month after series G funding from D1 Capital Partners.